Mable Therapy is the UK’s leading digital health platform for children’s speech and language therapy and counselling services.

The business addresses a significant and growing area of need – 1.4mn children in the UK have long-term speech, language or communication needs and one in five children aged 5-16 have a diagnosed mental health problem.

Mable offers an affordable direct-to-consumer service, as well as solutions for the education and healthcare sectors, where technology adoption is now seen as vital to address the growing unmet demand.

In the last year alone, Mable has delivered over 22,000 hours of therapy to over 3,000 children.

Investment rationale 

We invested £3.1mn into Mable Therapy in August 2023, to accelerate their growth and facilitate the development of an intra-therapy app designed to engage and empower children beyond session hours and school screening tools to help educators assess students’ mental health and speech & language needs.